Thai PBS Thai PBS
CCSA approves plan to buy 50,000 courses of anti-viral Molnupiravir drug

CCSA approves plan to buy 50,000 courses of anti-viral Molnupiravir drug

13 Sept 16:36 Key points summarised by AI
  • Thailand's Centre for COVID-19 Situation Administration (CCSA) approved the Public Health Ministry's proposal to procure 50,000 courses of Merck's anti-viral Molnupiravir drug, pending final cabinet approval.
  • The drug's high price of US$712 per five-day course has drawn criticism, with analyses indicating production costs are substantially lower, leading to accusations of profiteering.
Read full article
News 1/1
Skip > Skip >